Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Clinical Applications of Multiplex Analysis of Circulating Tumor DNA Biomarkers in Lung Cancer Patients

NCT03301961 is registered in ClinicalTrials.gov with Peking University People's Hospital as lead sponsor.

NCT NCT03301961
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03301961 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Clinical Applications of Multiplex Analysis of Circulating Tumor DNA Biomarkers in Lung Cancer Patients
Lead sponsor
Peking University People's Hospital
Phase
Observational
Overall status
Unknown status
Start date
April 11, 2019
Completion date
June 1, 2022
Enrollment
400 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoma, lung neoplasm, non-small-cell lung cancer